Did anyone consider the fact that Steel Partners has continually increased its holdings in Aderans at a time when Aderans is performing poorly?
Has anyone considered the fact that all start-up companies (like Intercytex) generally sell their technolgy to larger companies ? (Remember that ARI bought Bioamide , acquired technolgy rights and assumed the employment of Dr. Thomas Barrows, as an example.)
Would Intercytex have gotten approval for a government grant for adminstering the ICX-TRC process via robotics if the technolgy was not already proven?
Is it not possible that ARI and Intercytex already have a verbal agreeent that would allow ADERANS to buy the ICX-TRC technolgy from Intercytex outright? Would Bosly then qualify as the “company specializing in aesthetics” that ICX feels would better administer this process, as referenced in their press release?
Would this not explain Steel Partners’ financial interest in Aderans?
PS: TAGOHL - don’t forget to renew your ISHRS membership.
NOTE: The above is pure speculation. Or is it?